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Monocytes derived from the peripheral blood of pso-
riatic patients demonstrated a significantly higher 
phagocytic capacity (36 to 40%) for both 12f'I-labeled Shi-
gella flexneri and 125I_Iabeled Staphylococcus albus com-
pared with monocytes from healthy subjects. Monocytes 
from psoriatic patients showed a 2-to-4fold increase in 
bactericidal capacity against S. albus when compared 
with normal monocytes. ,However, the bactericidal ca-
pacity ofmonocytes from diphylline-treated patients did 
not differ from that ofthe control subjects. The antibody-
dependent cellular cytotoxicity (ADCC) activity against 
EL4 tumor cells was found to be s imilar in both psoriatic 
patients and control subjects. 
It is postulated that these abnormalities of monocyte 
function in psoriasis are caused by a decreased cAMP / 
cGMP ratio similar to the decreased cAMP / cGMP ratio 
found in the lesional epidermis of this disease. It seems 
therefore, that the psoriatic abnormality is not confined 
to only one type of cell, the epidermal cell. 
In a previous study [1], we showed t hat neutrophils derived 
from psoriatic patients have enhanced chemotactic and 
phagocytic activities compared with neutrophils from healthy 
subjects. Since these findings were unrelated to the extent of 
the eruption, we came to the conclusion that there is a basjc 
intrinsic abnormality of function in psoriatic neutrophils. As it 
is known that increased cyclic AMP levels inhibit chemotaxis 
and phagocytosis [2,3] while increased cyclic GMP levels en-
hance chemotaxis [3-5], it seemed possible to assume that this 
basic abnormality of neutrophil function in psoriasis might be 
caused by a decreased cAMP /cGMP ratio, similar to the de-
creased cAMP /cGMP ratio found in the lesional epidermis of 
this disease [6]. If the basic abnormality of psoriasis is not only 
confined to the epidermal celi, then one may expect to find it in 
additional cell types also. In searching for such an abnormality, 
we decided 'to investigate various aspects of monocyte function 
in psoriasis_ 
SUBJECTS AND METHODS 
Seventeen psoria tic patients aged between 20 and 62 yr, and 8 
healthy human volun teers (hospital and laboratory personnel) aged 
between 22 and 55 yr) were studied. There was no history of any 
previous or present infection in any of the patients studied and none of 
them had been receiving oral steroids or immunosuppressive dl'UgS 
during the last ye~. Four of the pa tients s tudied were being treated 
ora lly with Diphylline (7) for a period ranging between 1 and 4 mo. 
The clinical condit ion of these patients had markedly improved under 
this form of therapy. 
Monocyte Cultures 
Monocytes were separated from heparinized blood by the Ficoll-
Hypaque method (8) . Monolayer cultures of monocytes were obta ined 
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by cult ivating 3 x 10" monoculear cells per well on t issue culture 
microplates (6 mm well , Nunc, Denmark) in RPMI-1640 medium 
conta ining 5% heat- inactivated fetal calf serum (FCS) (9). The cells 
were incubated for 3 hr at 37°C in a humidified atmosphere containing 
5% CO2. Nonadhering cells were removed by repeated rins ing with 
phosphate buffered saline (PBS), and fresh medium was subsequently 
added. The remaining plastic-adhering cells (about 10" cells/ well) con-
sisted of more than 95% monocytes and less than 3% granulocytes, as 
was determined by nonspecific estrase staining. The number of plastic-
adhering cells was determined by a modification of the NA2r. 'Cr 0 ,,-
up take method as described by More et a l (10). Microscopic counting 
showed no difference in the number of adhering monocytes from 
healthy and psoriatic subjects. 
Phagocytic Assay 
Alcohol killed bacteria were fixed with 0.25% glu taraldehyde and 
iodinated with '2"I-labeled Na (Carrier free, Amersham, England) (11). 
Two mCI '2f'I were used for the labeling of 400 mg (wet weight) bacteria. 
The final in tensity of labeling was 400 bacteria/count per minute and 
200 bacteria per cpm for Shigella flexneri and S taphylococcus albus, 
respectively. The labeled bacteria were added to the monocyte cultures 
at a concentra tion of 2.4 x 107 bacteria (6-12 x 10' cpm) per 100 /Ll! 
well. The cul tures were incubated for various periods of time and 
phagocytosis was assessed by counting every well of a cut microtissue 
culture plate in a Packard 5110 scin tillation coun ter (12) . 
Bactericidal Assay 
Saline suspension of S . albus in the log phase of growth was added 
to the monocyte cultures at a ra tio of 100 bacteria/cell. After incubation 
for 30 min at 37°C, the nonphagocytosed bacteria were removed by 
intensive rins ing, and the monocyte mono layers were incubated for 
additional 30 and 60 min. The cells were then washed and lysed for 3 
min with 0.1 % Triton x-100. The number of viable staphylococci was 
determined by plating appropriate dilutions of the lysate in brain-heart 
agar . After 24 hr of incubation on agar plates at 37°C. the colonies were 
counted. 
Antibody-Dependent Cellular Cytotoxicity (ADCC) Assay. 
The t"Cr-release assay of Brunner et al (13) was used, under modified 
conditions. T en million tumor target cells (EL" a chemically induced 
leukemia of C57BL/ 6 mice) (14) in 1 ml RPMI-1640 medium were 
labeled with 200 /LCi of t" Cr (Sodium chromate, Amersham, England) 
for 45 min at 37°C with occasional shaking. The cells were washed 3 
times in 30 ml of cold RPMI medium and adjusted to a concentra tion 
of 1 x lOr. / ml in RPMI .containing 10% FCS. 0.1 ml of the labeled cells 
was added to the monocyte cultures, giVi ng an effector target cell ratio 
of 10:1. Rabbit anti-EL" antibodies diluted 1:100 in RPMI medium (0. 1 
ml) were added to the monocyte monolayers. The cell mixtures in 
triplicate were incubated for 4 hr at 37°C in a humidified atmosphere 
of 5% CO2 in air. The reaction was terminated by centrifuging the tissue 
culture microplates at 4°C for 10 min at 250 x g. S upernatant samples 
of 0.1 ml were t ransferred to new tubes and coun ted in a gamma 
scintillation counter. The percent specific lysis was calculated as fo l-
lows: ((A-Bl / (C-B)) x 100, where A = counts of test sample, B = coun ts 
of cont rol samples with monocytes cultured without anti-EL, anti-
bodies, and C = counts of maximal "'Cr-release affected by 3 cycles of 
freezing and thawing in 1 ml of distilled water. T he spontaneous "'Cr-
release (target cells incubated in medium or in the presence of mono-
cytes without anti-EL" antibodies) was in the range of 5 to 10%; whereas 
the maximal release ranged from 80 to 85% of the total amount of t" Cr 
that was incorporated. 
The results of patients and controls were compared using the one-
ta iled Mann-Whitney U-test (20). 
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RESULTS 
Phagocytosis of K illed S. {lexneri and S. albus 
Monocytes from 12 untreated psoriatic patients a nd 5 healthy 
subjects were examined. The monocytes from the psoriatic 
patients exhibited a significantly increased phagocytic capacity 
for both S. {lexneri and S. albus when compared with normal 
monocytes (p < 0.02). T he mean uptake for each bacterium by 
the monocytes from psoriatic patients was about 40% higher 
than by those from the control subj ects. 
Figure 1 shows a representative experiment that consisted of 
2 psoriatic patients and two control subjects. The phagocytic 
capacity of the cells from psoriatic patients for both 12"I-Iabeled 
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FIG 1. Phagocytosis of ''''I- labeled Shigella flexneri and ' ~" I-labeled 
Staphylococcus albus by monocytes from 2 psoriatic patients and 2 
control subjects. Each point represents the mean of 3 determinations. 
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S. {lexneri and S. albus was higher th an that of th e control 
subjects during the 60 min of incubation. Figure 2 summarizes 
the results of phagocytosis by monocytes from all the psoriatic 
patients and control subjects after one hour of incubation. 
Phagocytosis of Viable S. albus 
Monocytes from 8 untreated psoriatic patients and 3 healthy 
subjects were examined. The phagocytosis of viable S. albus 
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FIG 2. Phagocytosis of ''''I-labeled Shigella flexneri and '"" I-labeled 
Staphylococcus albus by monocytes from psoriatic patients and healthy 
subjects after 1 hI' of incubation. Each dot represents one subject. The 
mean for each group is shown as a solid line ± S.D. Note increased 
phagocytosis in psoriatic patients (p < 0.02 for each of the bacteria). 
TABLE 1. Killing of Staphylococcus albus by monocytes derived from untreated psoriatic patients. 
Subjects No. bacteria Relative No. bacteria Relative 
Exp. No. per monocyte bactericidal per monocyte bactericidal 
Normal Psoriatic a fter 30 min activity after 60 min activity 
Z.M 4.8 174 7.7 167 
S.M 6.3 152 6.4 173 
S.L 3.1 177 11.2 . 152 
F.Y 12.8 13.1 100 
17.1 23.0 100 
A.W 13.5 28.9 
2 L.N 3.4 142 10.2 120 
B.Y 4.7 119 N.D 
Y.Y 4.1 130 6.0 153 
Z.M 2.2 163 16.2 72 
E.S 5.7 5.8 100 
9.1 12.6 100 
T.D 5.9 16.1 
3 A.L 2.2 172 4.8 168 
P.S 1.7 180 6.5 157 
S.Z 4.5 145 7.1 153 
G.Z 5.2 136 12.0 120 
L.E 4.9 140 10.4 ' 131 
S.A 5.6 8.1 100 
11.2 14.9 100 
S.B 10.6 18.7 
Mean ± SD 6 12 152.5 ± 20 149.4 ± 19 
p<O.Ol" p<O.Ol" 
"One-tailed Mann-Whitney U-test. 
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TABLE II. Killing of Staphylococcus albus by monocytes derived from diphylline-treated psoriatic patients compared with healthy subjects 
Healthy 
A.W 
M.B 
Mean ± SD 
Subjects 
Psoriatic 
A.L 
M.C 
S.S 
Y.A 
5 
" P ercent of normal monocytes. 
"One-tailed Mann-Whitney U-test. 
No. of bacteria 
per monocyte 
after 30 min 
6.0 
12.2 
10.8 
8.9 
8.9 9.0 9.0 
p>0.40" 
after 30 min of incubation was similar in both psoriatic patients 
and control subjects (p > 0.1). 
Bactericidal Activity of Monocytes 
S urvival of phagocytosed viable S. albus was assessed 30 and 
60 min following their engulfment by monocytes from 12 un-
treated psoriatic patients and 6 control subjects (Table I). The 
bactericidal capacity of monocytes from psoriatic patients was 
found to be significantly higher after both 30 and 60 min when 
compared with normal monocytes (p < 0.01 and p < 0.01 
respectively). The number of live intracellular bacteria per 
monocyte was up to 4 times lower in the psoriatic patients than 
in that of the control subjects. However, the bactericidal capac-
ity of monocytes from diphylline-treated patients (Table II) did 
not differ from that of the control subjects (p > 0.40; P > 0.60). 
The killing of EL4 leukemia tumor cells coated with specific 
anti-EL4 antibodies by monocytes from 6 untreated psoriatic 
patients and 2 normal subjects was examined. The cytotoxic 
effect of monocytes derived from psoriatic patient..c; and from 
control subjects against EL, was similar (p > 0.1). 
DISCUSSION 
Our present study demonstrated an enhancement in phago-
cytic and bactericidal capacities of monocytes derived from 
untreated psoriatic patients compared with those from healthy 
subjects. These findings are analogous to the enhanced che-
motactic and phagocytic activities of psoriatic neutrophils de-
scribed in our previous study [1]. We have recently treated 
psoriatic patients with an orally-administered phosphodiester-
ase-inhibitor, diphylline, with encouraging results [7]. The ra-
tionale for this form of therapy was that diphylline might 
increase the intracellular levels of cyclic AMP thus restoring 
the presumably decreased intraepidermal cAMP/cGMP ratio 
in the lesional epidermis of psoriasis [6] to normal. As it is 
known that increased cAMP levels inhibit several phagocyte 
functions, while increased cGMP levels enhance these functions 
[2-5], it seems reasonable to assume that the enhanced neutro-
phil functions in psoriasis [1] as well as the enhanced monocyte 
functions in this disease-might be caused by a decreased 
cAMP/cGMP ratio, similar to the decreased cAMP/cGMP 
ratio found in the lesional epidermis of this disease [6]. Com-
patible with this hypothesis is the fact that successful treatment 
of the skin-lesions with an orally-administered phosphodiester-
ase inhibitor, diphyUine, lowered also the bactericidal activity 
of psoriatic monocytes to normal levels. The reason for the lack 
of enhancement of the ADCC activity of psoriatic monocytes is 
not clear. Microtubule-disruptive agents do not influence 
ADCC at concentrations that are not toxic to macrophages 
[17]; whereas they do inhibit other phagocyte functions, such 
as chemotaxis [18] and degranulation [19). Microtubule-asso-
ciated functions are therefore considered to be nonessential for 
ADCC in contrast with other macrophage functions [17]. It is 
possible that the basic anomaly of psoriasis consists of a state 
Relative No. of bacteria Relative 
bactericidal per monocyte bactericidal 
activity" after 60 min activity" 
134 15.0 141 
73 35.2 60.2 
83.3 17.3 122 
101 14.5 146 
100 15.7 21.2 100 26.7 
97.8 ± 26 117 ± 39 
p>0.60" 
of increased assemblage of microtubules; this, in turn, could 
explain the lack of enhancement of ADCC in this disease. 
These present findings as well as those reported in our 
previous study [1] lend support to the hypothesis that the 
psoriatic abnormality is not confmed to only one type of cell, 
the epidermal cell, as was previously assumed. 
Finally, solar keratoses and skin cancers are very rare in 
psoriatic patients [15,16]. These facts could be explained by the 
enhanced monocytes functions in psoriasis. 
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